Myasthenia gravis presents with fluctuating muscle weakness, often starting with ocular symptoms like ptosis and diplopia in adults.
Pediatric MG may present similarly to adults but can include congenital forms, complicating diagnosis.
Underdiagnosis is due to symptom variability, overlap with other conditions, and lack of awareness among healthcare providers.
Persistent muscle weakness, particularly with ocular involvement, and fatigue that worsens with activity should prompt specialist consultation.
SHOW MORE
Panelists discuss how myasthenia gravis presents clinically in adults and children, factors contributing to its underdiagnosis, and symptoms that should prompt specialist consultation.
Although underdiagnosed, myasthenia gravis (MG) is estimated to affect up to 60,000 individuals in the United States. Please describe the typical clinical presentation of MG in both adult and pediatric patients.
What factors contribute to the underdiagnosis of generalized MG? What symptoms should prompt a visit to a neurologist or a neuromuscular specialist?
The professor of neurology and program director of Neuromuscular Medicine at UC Irvine, discusses phase 3 NIMBLE trial findings for cemdisiran in generalized myasthenia gravis, including its novel siRNA mechanism, efficacy, and hospitalization data.
New 48-week phase 3 data show many patients with generalized myasthenia gravis reached minimal symptom expression on telitacicept, and most who did sustained it.
New analyses found differences in functional outcomes over 2 years among patients aged 8 to 12 years treated with delandistrogene moxeparvovec, while separate findings characterized micro-dystrophin expression in children younger than 3 years.
The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent therapeutic advances in MS!